Updated

Colossal Biosciences CEO Ben Lamm has outlined how the company's de-extinction efforts—bringing back extinct species such as dire wolves and woolly mammoths—could contribute to conservation, healthcare, and developmental biology. The company is positioning genetic resurrection technology as having applications beyond preserving biodiversity, suggesting potential medical and scientific benefits.